[HTML][HTML] Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite

D Danielak, M Karaźniewicz-Łada, A Komosa… - European Journal of …, 2017 - Springer
Purpose A high interindividual variability is observed in the pharmacokinetics of clopidogrel,
a widely used antiplatelet drug. In the present study, a joint parent-metabolite population …

Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite

D Danielak, M Karaźniewicz-Łada… - … journal of clinical …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose A high interindividual variability is observed in the pharmacokinetics of clopidogrel,
a widely used antiplatelet drug. In the present study, a joint parent-metabolite population …

Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite

D Danielak, M Karaźniewicz-Łada… - … Journal of Clinical …, 2017 - search.proquest.com
Purpose A high interindividual variability is observed in the pharmacokinetics of clopidogrel,
a widely used antiplatelet drug. In the present study, a joint parent-metabolite population …

Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite.

D Danielak, M Karaźniewicz-Łada… - European Journal of …, 2017 - europepmc.org
Purpose A high interindividual variability is observed in the pharmacokinetics of clopidogrel,
a widely used antiplatelet drug. In the present study, a joint parent-metabolite population …

[PDF][PDF] Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite

D Danielak, M Karaźniewicz, A Komosa… - Eur J Clin …, 2017 - academia.edu
Purpose A high interindividual variability is observed in the pharmacokinetics of clopidogrel,
a widely used antiplatelet drug. In the present study, a joint parent-metabolite population …

[HTML][HTML] Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite

D Danielak, M Karaźniewicz-Łada… - European Journal of …, 2017 - ncbi.nlm.nih.gov
Purpose A high interindividual variability is observed in the pharmacokinetics of clopidogrel,
a widely used antiplatelet drug. In the present study, a joint parent-metabolite population …

Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite.

D Danielak, M Karaźniewicz-Łada… - … Journal of Clinical …, 2017 - search.ebscohost.com
Purpose: A high interindividual variability is observed in the pharmacokinetics of clopidogrel,
a widely used antiplatelet drug. In the present study, a joint parent-metabolite population …

[PDF][PDF] Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite

D Danielak, M Karaźniewicz, A Komosa… - Eur J Clin …, 2017 - academia.edu
Purpose A high interindividual variability is observed in the pharmacokinetics of clopidogrel,
a widely used antiplatelet drug. In the present study, a joint parent-metabolite population …

Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite.

D Danielak, M Karaźniewicz-Łada… - European Journal of …, 2017 - europepmc.org
Purpose A high interindividual variability is observed in the pharmacokinetics of clopidogrel,
a widely used antiplatelet drug. In the present study, a joint parent-metabolite population …